BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.01B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$175M |
| 4 |
Merck
MRK
|
+$138M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$949M |
| 2 |
Bank of America
BAC
|
+$275M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$208M |
| 4 |
Canadian National Railway
CNI
|
+$154M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.39% |
| 2 | Financials | 8.44% |
| 3 | Consumer Discretionary | 6.01% |
| 4 | Industrials | 6% |
| 5 | Healthcare | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
ICU Medical
ICUI
$4.58B
| $130K | ﹤0.01% |
1,364
-2,487
| -65% | -$232K |
|
1902
Axalta
AXTA
$7.99B
| $130K | ﹤0.01% |
3,929
+2,702
| +220% | +$89.2K |
|
|
HIBB
1903
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $130K | ﹤0.01% |
2,785
+2,168
| +351% | +$104K |
|
1904
Cogent Communications
CCOI
$579M
| $130K | ﹤0.01% |
3,831
+2,727
| +247% | +$91.4K |
|
|
HA
1905
DELISTED
Hawaiian Holdings, Inc.
HA
| $129K | ﹤0.01% |
5,446
+4,370
| +406% | +$102K |
|
|
HTWR
1906
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $129K | ﹤0.01% |
1,778
-1,746
| -50% | -$136K |
|
|
SCTL
1907
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $129K | ﹤0.01% |
+11,150
| New | +$104K |
|
|
MANT
1908
DELISTED
Mantech International Corp
MANT
| $129K | ﹤0.01% |
4,452
+1,980
| +80% | +$59.9K |
|
|
FMBI
1909
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $129K | ﹤0.01% |
6,795
+5,013
| +281% | +$89.8K |
|
|
LOCK
1910
DELISTED
LifeLock, Inc.
LOCK
| $129K | ﹤0.01% |
7,851
+5,938
| +310% | +$91.8K |
|
|
OSG
1911
Octave Specialty Group
OSG
$221M
| $129K | ﹤0.01% |
7,736
+6,332
| +451% | +$149K |
|
|
CSR
1912
Centerspace
CSR
$938M
| $129K | ﹤0.01% |
1,802
+814
| +82% | +$58.9K |
|
1913
The Greenbrier Companies
GBX
$1.41B
| $129K | ﹤0.01% |
2,743
+2,088
| +319% | +$125K |
|
1914
Franklin Electric
FELE
$4.68B
| $128K | ﹤0.01% |
3,962
+2,822
| +248% | +$101K |
|
1915
Albany International
AIN
$1.84B
| $128K | ﹤0.01% |
3,217
+2,549
| +382% | +$102K |
|
1916
AAR Corp
AIR
$5.85B
| $128K | ﹤0.01% |
4,017
+3,080
| +329% | +$93.9K |
|
1917
Innoviva
INVA
$1.53B
| $128K | ﹤0.01% |
7,084
+5,133
| +263% | +$88.2K |
|
1918
Tennant Co
TNC
$1.17B
| $128K | ﹤0.01% |
1,956
+1,521
| +350% | +$99.6K |
|
|
AY
1919
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $128K | ﹤0.01% |
4,080
+3,408
| +507% | +$122K |
|
|
MZTI
1920
The Marzetti Company
MZTI
$3.18B
| $128K | ﹤0.01% |
1,405
+1,029
| +274% | +$94.4K |
|
|
AEGN
1921
DELISTED
Aegion Corp
AEGN
| $127K | ﹤0.01% |
6,692
-296
| -4% | -$5.45K |
|
1922
Essent Group
ESNT
$6.25B
| $126K | ﹤0.01% |
4,624
+3,569
| +338% | +$91.8K |
|
1923
Ironwood Pharmaceuticals
IRWD
$712M
| $126K | ﹤0.01% |
12,510
+9,118
| +269% | +$106K |
|
1924
TriMas Corp
TRS
$1.4B
| $126K | ﹤0.01% |
5,335
+3,986
| +295% | +$95K |
|
1925
Westamerica Bancorp
WABC
$1.38B
| $125K | ﹤0.01% |
2,476
+1,855
| +299% | +$85.3K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2015 Portfolio in Review
As of Q2 2015, BNP Paribas Financial Markets held 3,782 positions worth $35.8B, down 0.81% from $36.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets's Q2 2015 filing shows 210 new, 2,320 increased, 874 reduced and 237 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M. The largest sale was Apple, an estimated $949M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2015 buy was Vanguard S&P 500 ETF: 300,000 shares worth $56.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.01B increase.
- BNP Paribas Financial Markets's biggest Q2 2015 reduction was Apple, cutting an estimated $949M.
- BNP Paribas Financial Markets fully exited Allergan plc in Q2 2015, selling an estimated $55.7M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $35.8B portfolio in Q2 2015.
- BNP Paribas Financial Markets opened 210 new positions and closed 237 in Q2 2015.
- BNP Paribas Financial Markets's portfolio value fell 0.81% quarter-over-quarter to $35.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2015, filed 14 Aug 2015.